( en | de | ru )

 

Disambiguation of "Bartenschlager, R"

Author of the publication

copydeleteadd this publication to your clipboard
Maturation of secreted HCV particles by incorporation of secreted apoE protects from antibodies by enhancing infectivity

, , , , , , , , , , and . J Hepatol, 67 (3): 480-489 (2017)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Jan Bartenschlager

Georg Bartenschlager

Ralf Bartenschlager

Ralf Bartenschlager

Ralf Bartenschlager

 

Other publications of authors with the same name

Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations, , , , , , , , , and . PLoS Pathog, 5 (6): e1000475 (2009)Soraphen A: a broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity, , , , , , , , , and 5 other author(s). J Hepatol, 63 (4): 813-821 (2015)MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles, , , , , , , , , and . PLoS Pathog, 8 (7): e1002829 (July 2012)Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication via blockage of membranous web formation, , , , , , , , , and 7 other author(s). Hepatology, 62 (3): 702-714 (2015)Maßgeschneiderte Therapie der Virushepatitis der Gegenwart und Zukunft, , and . Der Internist, 58 (7): 666-674 (Jul 1, 2017)Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies, , , , , , , , , and 2 other author(s). Virus Res, (2018)Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors, , , , , , , , , and 2 other author(s). Angew Chem Int Ed Engl, 61 (52): e202212946 (October 2022)Immune protection against reinfection with nonprimate hepacivirus, , , , , , , , , and 13 other author(s). Proc Natl Acad Sci U S A, 114 (12): E2430-E2439 (March 2017)Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles, , , , and . J Virol, 82 (14): 7034-7046 (July 2008)Characterization of determinants important for hepatitis C virus p7 function in morphogenesis using trans-complementation, , , , , , , and . J Virol, 83 (22): 11682-11693 (2009)